[HTML][HTML] Ultramicronized N-palmitoylethanolamine associated with analgesics: Effects against persistent pain

S Nobili, L Micheli, E Lucarini, A Toti… - Pharmacology & …, 2024 - Elsevier
Current epidemiological data estimate that one in five people suffers from chronic pain with
considerable impairment of health-related quality of life. The pharmacological treatment is …

Therapeutic Use of Palmitoylethanolamide as an Anti-inflammatory and Immunomodulator

MCI Sá, MGM Castor - Future Pharmacology, 2023 - mdpi.com
Palmitoylethanolamine (PEA) is an endocannabinoid-like compound first encountered
within the lipid fractions of specific foods and has intrigued researchers since the 1950s due …

Therapeutic Potential of Palmitoylethanolamide in Gastrointestinal Disorders

M Branković, T Gmizić, M Dukić, M Zdravković… - Antioxidants, 2024 - mdpi.com
Palmitoylethanolamide (PEA) is an endocannabinoid-like bioactive lipid mediator belonging
to the family of N-acylethanolamines, most abundantly found in peanuts and egg yolk. When …

Novel drug treatments for pain in advanced cancer and serious illness: a focus on neuropathic pain and chemotherapy-induced peripheral neuropathy

MP Davis - Palliative Care and Social Practice, 2024 - journals.sagepub.com
Drugs that are commercially available but have novel mechanisms of action should be
explored as analgesics. This review will discuss haloperidol, miragabalin …

Utilização terapêutica da Palmitoiletanolamida (PEA) como anti-inflamatório e imunomodulador

MCI de Sá - 2023 - repositorio.ufmg.br
RESUMO O sistema endocanabinoide compreende os receptores canabinoides, os ligantes
endógenos denominados endocanabinoides e as enzimas, relacionadas a processos de …

Endogenous opiates and behavior: 2023

RJ Bodnar - Peptides, 2024 - Elsevier
This paper is the forty-sixth consecutive installment of the annual anthological review of
research concerning the endogenous opioid system, summarizing articles published during …